Post-Acute COVID-19 Syndrome
a 12-month telemonitoring cohort to assess the persistent symptoms and the quality of life
DOI:
https://doi.org/10.47456/rbps.v27i1.47684Keywords:
Post-Acute COVID-19 Syndrome, COVID-19, SARS-CoV-2, Quality of life, TelemonitoringAbstract
Introduction: After the end of the COVID-19 pandemic, another colossal challenge continues to be faced by the health system worldwide: the post-acute COVID-19 syndrome. Objectives: This study aimed to evaluate respiratory symptoms and QoL (quality of life) in a cohort of previously hospitalized COVID-19 patients after twelve months of discharge. Additionally, the study aimed to identify clinical factors related to these symptoms. Methods: This longitudinal study, with a 12-month cohort, was conducted with adults discharged home after hospitalization for COVID-19. Twelve months post-discharge, the participants were assessed through video or phone calls and answered a questionnaire regarding persistent symptoms and QoL. The modified Medical Research Council scale (mMRC) was used to grade the impact of dyspnea on daily activities, and the WHOQoL-BREF questionnaire was used to assess the QoL. Results: The cohort included 15 patients, with a mean age of 63.53±7.32 years. Twelve months after discharge, 10 (66.66%) individuals suffered from at least one symptom, among which 40% reported cough, 20% reported fatigue, 20% had dyspnea at rest, and 40% had dyspnea during activities. The physical domain of QoL had the lowest score (9.14±3,54) among the WHOQoL domains. Age, sex, diabetes, and mMRC≥1 correlated with QoL. Conclusion: The high prevalence of respiratory symptoms and impaired QoL even 12 months after hospital discharge highlight the need to adopt protocols for in-hospital rehabilitation and prepare patients for practice physical activity or exercise-based rehabilitation programs after discharge.
Downloads
References
Antoniou KM, Vasarmidi E, Russell AM, Andrejak C, Crestani B, Delcroix M, et al. European Respiratory Society statement on long COVID follow-up. Eur Respir J. 2022;60(2):2102174. doi: 10.1183/13993003.02174-2021.
Sisó-Almirall A, Brito-Zerón P, Conangla Ferrín L, Kostov B, Moragas Moreno A, Mestres J, et al. Long COVID-19: proposed primary care clinical guidelines for diagnosis and disease management. Int J Environ Res Public Health. 2021;18(8):4350. doi: 10.3390/ijerph18084350.
Abreu LC. Four years into the era of COVID-19: the virus persists and global vaccination efforts remain quiescent. J Hum Growth Dev. 2023;33(3):315-318. doi: 10.36311/jhgd.v33.15423.
Alkodaymi MS, Omrani OA, Ashraf N, Abou Shaar B, Almamlouk R, Riaz M, et al. Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis. Clin Microbiol Infect. 2022;28(5):657-666. doi: 10.1016/j.cmi.2022.01.014.
Natarajan A, Shetty A, Delanerolle G, Zeng Y, Zhang Y, Raymont V, et al. A systematic review and meta-analysis of long COVID symptoms. Syst Rev. 2023;12(1):88. doi: 10.1186/s13643-023-02250-0.
Boscolo-Rizzo P, Guida F, Polesel J, Marcuzzo AV, Capriotti V, D’Alessandro A, et al. Sequelae in adults at 12 months after mild-to-moderate coronavirus disease 2019 (COVID-19). Int Forum Allergy Rhinol. 2021;11(12):1685-1688. doi: 10.1002/alr.22832.
Gentilotti E, Górska A, Tami A, Gusinow R, Mirandola M, Rodríguez-Baño J, et al. Clinical phenotypes and quality of life to define post-COVID-19 syndrome: a cluster analysis of the multinational, prospective ORCHESTRA cohort. EClinicalMedicine. 2023;62:102107. doi: 10.1016/j.eclinm.2023.102107.
Crisafulli E, Clini EM. Measures of dyspnea in pulmonary rehabilitation. Multidiscip Respir Med. 2010;5(3):202. doi: 10.1186/2049-6958-5-3-202.
Fleck MPA, Louzada S, Xavier M, Chachamovich E, Vieira G, Santos L, et al. Aplicação da versão em português do instrumento abreviado de avaliação da qualidade de vida “WHOQOL-bref”. Rev Saude Publica. 2000;34(2):178-183. doi: 10.1590/S0034-89102000000200012.
Adebayo BI, Adejumo OA, Odusanya OO. Health-related quality of life among adults newly diagnosed with pulmonary tuberculosis in Lagos State, Nigeria: a prospective study. Qual Life Res. 2024;33(1):157-168. doi: 10.1007/s11136-023-03506-x.
Nikrah N, Bahari F, Shiri A. Effectiveness of the acceptance and commitment therapy on resilience and quality of life in patients with post-acute COVID-19 syndrome. Appl Nurs Res. 2023;73:151723. doi: 10.1016/j.apnr.2023.151723.
Fernández-de-las-Peñas C, Guijarro C, Plaza-Canteli S, Hernández-Barrera V, Torres-Macho J. Prevalence of post-COVID-19 cough one year after SARS-CoV-2 infection: a multicenter study. Lung. 2021;199(3):249-253. doi: 10.1007/s00408-021-00450-w.
Huang L, Yao Q, Gu X, Wang Q, Ren L, Wang Y, et al. 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study. Lancet. 2021;398(10302):747-758. doi: 10.1016/S0140-6736(21)01755-4.
Lombardo MDM, Foppiani A, Peretti GM, Mangiavini L, Battezzati A, Bertoli S, et al. Long-term coronavirus disease 2019 complications in inpatients and outpatients: a one-year follow-up cohort study. Open Forum Infect Dis. 2021;8(8):ofab384. doi: 10.1093/ofid/ofab384.
Steinbeis F, Thibeault C, Doellinger F, Ring RM, Mittermaier M, Ruwwe-Glösenkamp C, et al. Severity of respiratory failure and computed chest tomography in acute COVID-19 correlates with pulmonary function and respiratory symptoms after infection with SARS-CoV-2: an observational longitudinal study over 12 months. Respir Med. 2022;191:106709. doi: 10.1016/j.rmed.2021.106709.
Maestre-Muñiz MM, Arias Á, Mata-Vázquez E, Martín-Toledano M, López-Larramona G, Ruiz-Chicote AM, et al. Long-term outcomes of patients with coronavirus disease 2019 at one year after hospital discharge. J Clin Med. 2021;10(13):2945. doi: 10.3390/jcm10132945.
Seeßle J, Waterboer T, Hippchen T, Simon J, Kirchner M, Lim A, et al. Persistent symptoms in adult patients 1 year after coronavirus disease 2019 (COVID-19): a prospective cohort study. Clin Infect Dis. 2022;74(7):1191-1198. doi: 10.1093/cid/ciab611.
Grewal JS, Carlsten C, Johnston JC, Shah AS, Wong AW, Ryerson CJ. Post-COVID dyspnea: prevalence, predictors, and outcomes in a longitudinal, prospective cohort. BMC Pulm Med. 2023;23(1):84. doi: 10.1186/s12890-023-02376-w.
D’Cruz RF, Waller MD, Perrin F, Periselneris J, Norton S, Smith LJ, et al. Chest radiography is a poor predictor of respiratory symptoms and functional impairment in survivors of severe COVID-19 pneumonia. ERJ Open Res. 2021;7(1):00655-2020. doi: 10.1183/23120541.00655-2020.
Betschart M, Rezek S, Unger I, Ott N, Beyer S, Böni A, et al. One year follow-up of physical performance and quality of life in patients surviving COVID-19: a prospective cohort study. Swiss Med Wkly. 2021;151:w30072. doi: 10.4414/smw.2021.w30072.
Bouteleux B, Henrot P, Ernst R, Grassion L, Raherison-Semjen C, Beaufils F, et al. Respiratory rehabilitation for COVID-19 related persistent dyspnoea: a one-year experience. Respir Med. 2021;189:106648. doi: 10.1016/j.rmed.2021.106648.
Fischer A, Zhang L, Elbéji A, Wilmes P, Oustric P, Staub T, et al. Long COVID symptomatology after 12 months and its impact on quality of life according to initial coronavirus disease 2019 disease severity. Open Forum Infect Dis. 2022;9(8):ofac397. doi: 10.1093/ofid/ofac397.
Verveen A, Wynberg E, van Willigen HDG, Davidovich U, Lok A, Moll van Charante EP, et al. Health-related quality of life among persons with initial mild, moderate, and severe or critical COVID-19 at 1 and 12 months after infection: a prospective cohort study. BMC Med. 2022;20(1):422. doi: 10.1186/s12916-022-02615-7.
Yang T, Yan MZ, Li X, Lau EHY. Sequelae of COVID-19 among previously hospitalized patients up to 1 year after discharge: a systematic review and meta-analysis. Infection. 2022;50(5):1067-1109. doi: 10.1007/s15010-022-01862-3.
Mastrorosa I, Del Duca G, Pinnetti C, Lorenzini P, Vergori A, Brita AC, et al. What is the impact of post-COVID-19 syndrome on health-related quality of life and associated factors: a cross-sectional analysis. Health Qual Life Outcomes. 2023;21(1):28. doi: 10.1186/s12955-023-02107-z.
O’Brien K, Townsend L, Dowds J, Bannan C, Nadarajan P, Kent B, et al. 1-year quality of life and health-outcomes in patients hospitalised with COVID-19: a longitudinal cohort study. Respir Res. 2022;23(1):115. doi: 10.1186/s12931-022-02032-7.
Caamano E, Velasco L, Garcia MV, Asencio JM, Piñeiro P, Hortal J, et al. Prognostic factors for deterioration of quality of life one year after admission to ICU for severe SARS-CoV-2 infection. Qual Life Res. 2024;33(1):123-132. doi: 10.1007/s11136-023-03503-0.
Martínez-Pozas O, Meléndez-Oliva E, Rolando LM, Rico JAQ, Corbellini C, Sánchez Romero EA. The pulmonary rehabilitation effect on long COVID-19 syndrome: a systematic review and meta-analysis. Physiother Res Int. 2024;29(2):e2077. doi: 10.1002/pri.2077.
Zeleke AJ, Moscato S, Miglio R, Chiari L. Length of stay analysis of COVID-19 hospitalizations using a count regression model and quantile regression: a study in Bologna, Italy. Int J Environ Res Public Health. 2022;19(4):2224. doi: 10.3390/ijerph19042224.
Thomas P, Baldwin C, Beach L, Bissett B, Boden I, Cruz SM, et al. Physiotherapy management for COVID-19 in the acute hospital setting and beyond: an update to clinical practice recommendations. J Physiother. 2022;68(1):8-25. doi: 10.1016/j.jphys.2021.12.012.
Wittmer VL, Paro FM, Duarte H, Capellini VK, Barbalho-Moulim MC. Early mobilization and physical exercise in patients with COVID-19: a narrative literature review. Complement Ther Clin Pract. 2021;43:101364. doi: 10.1016/j.ctcp.2021.101364.
Dias LMS, Guimaraes FS, Leite CF, Paro FM, Annoni R, Oliveira ACO, et al. Physiotherapy practice for hospitalized patients with COVID-19. J Bras Pneumol. 2022;48(4):e20220121. doi: 10.36416/1806-3756/e20220121.
Volpe MS, Dias LMS, Leite CF, Annoni R, Paro FM, Oliveira ACO, et al. Chest physiotherapy techniques administered by certified specialists to hospitalized patients with COVID-19 in Brazil: a look towards future practice. Heart Lung. 2023;62:87-94. doi: 10.1016/j.hrtlng.2023.06.005.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Brazilian Journal of Health Research
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The Revista Brasileira de Pesquisa em Saúde (RBPS) adopts the CC BY 4.0 license, which means that authors retain the copyright of the works they submit to the journal. Authors are responsible for declaring that their contribution is an original manuscript, that it has not been previously published, and that it is not under simultaneous review by another scientific journal. Upon submitting the manuscript, authors grant RBPS the exclusive right of first publication, subject to peer review.
Authors are permitted to enter into additional contracts for the non-exclusive distribution of the version published by RBPS (for example, in institutional repositories or as a book chapter), provided that due acknowledgment of authorship and of initial publication by RBPS is given. Authors are also encouraged to make their work available online (for example, in institutional repositories or on their personal pages) after its initial publication in the journal, with due acknowledgment of authorship and of the original publication by RBPS.
Accordingly, under the CC BY 4.0 license, readers have the right to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially;
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
The licensor cannot revoke these freedoms as long as you follow the license terms. Under the following terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
